Clinical trial

Safety and Dose-Response of Bletilla Formosana in Prediabetic Subjects

NCT07704944

Study summary

ClinicalTrials.gov

Safety and Dose-Response of Bletilla Formosana in Prediabetic Subjects

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE1, PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Bletilla formosana (BF) powder Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-07-01

PhasePHASE1 / PHASE2

Conditions

Prediabetesverified · MONDO: prediabetes syndrome

Interventions

Bletilla formosana (BF) powderDRUG

PlaceboOTHER

Sponsors & collaborators

Chang Gung Memorial Hospitallead sponsor

National Science and Technology Councilcollaborator

Mapped research locations

TaoyuanTaiwan2 KeelungTaiwan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07704944 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.